Our corporate headquarters are located in Marietta, Georgia, where we lease office, laboratory, tissue processing and warehouse space.
−Removed: We lease a facility in Kennesaw, Georgia, which primarily consists of laboratory, tissue processing and warehouse space, and are currently subletting additional warehouse space in Marietta, Georgia through May 31, 2023.
−Removed: Our properties, excluding the sublet space, are used by our Wound & Surgical segment, which includes the design, manufacture and marketing of products and tissue processing services primarily for the wound care, burn, Surgical Recovery, and non-operative sports medicine sectors of healthcare, additionally, our Kennesaw facility is used for the Regenerative Medicine segment.
−Removed: The Company’s properties are suitable and adequate for current business operations.
−Removed: We are making investments to increase our manufacturing capacity, as well as enhancements to facilitate the processing of products required to be manufactured under CGMP.
+Added: We also lease a facility in Kennesaw, Georgia, which primarily consists of laboratory, tissue processing and warehouse space.
+Added: Our properties are used for the design, manufacture and marketing of Wound & Surgical product portfolio.
+Added: We believe that such properties are suitable and adequate to meet the needs of our business.
Legal Proceedings
−Removed: The description of our securities class action and the Welker v.
+Added: The description of the Welker v.
case contained in Note 16, Commitments and Contingencies to our financial statements included in Item 8 is incorporated herein by reference.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.